EUVIMEDEUVIMED entdecken
Open Access

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir

Yuta Nakamaru, Ken-Ichi Sako, Naohito Ide, Yoshikazu Matsuda, Fumiyoshi Yamashita, Tomoji Maeda

In Vivo · 2025

DOI: 10.21873/invivo.14005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Yuta Nakamaru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan. Hauptthemen laut MEDLINE: Lopinavir, Ritonavir, COVID-19 Drug Treatment, Antiviral Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LopinavirRitonavirCOVID-19 Drug TreatmentAntiviral AgentsHumansSARS-CoV-2COVID-19MaleDrug CombinationsAdultComputer SimulationHIV InfectionsMiddle AgedFemaleDrug Therapy, CombinationDose-Response Relationship, Drug

Stichwörter der Autor:innen

COVID-19Pharmacokineticsdrug repurposingpharmacokinetic boostingsimulation

Substanzen

LopinavirRitonavirDrug Combinationslopinavir-ritonavir drug combinationAntiviral Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan.
  • Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
  • Department of Clinical Pharmacy, Nihon Pharmaceutical University, Saitama, Japan; t-maeda@nichiyaku.ac.jp.

Zitieren

APA

Nakamaru, Y., Sako, K. I., Ide, N., Matsuda, Y., Yamashita, F., & Maeda, T. (2025). Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir. In Vivo. https://doi.org/10.21873/invivo.14005

Vancouver

Nakamaru Y, Sako KI, Ide N, Matsuda Y, Yamashita F, Maeda T. Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir. In Vivo. 2025. doi:10.21873/invivo.14005

BibTeX
@article{Nakamaru2025,
  author = {Nakamaru, Yuta and Sako, Ken-Ichi and Ide, Naohito and Matsuda, Yoshikazu and Yamashita, Fumiyoshi and Maeda, Tomoji},
  title = {Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14005}
}
Kostenlos starten →